Testing New Formats for the Presentation of Research Evidence to Health Care Managers and Policy Makers

NCT03041454 | Completed

• 1 other identifier: SMH-312381
• Study Type: interventional
• Target: 257
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this project is to identify and use our knowledge on the barriers and facilitators to using systematic reviews (SR) by health care managers (HCM) and policy markers (PM) to develop and test a novel format for presentation of SR for HCM and PM. We will invite HCM and PM from hospitals and regional authorities in Ontario, Alberta, and British Columbia to participate in a randomized-control trial. Participants will receive a link to an online consent survey, and then be randomly allocated to receive access to a novel SR or its traditional presentation. There is no time limit to completing the task, and participants are able to save their responses and finish later. Participants are able to withdraw from the study by not completing the task.

Conditions

Uptake of Systematic Review Evidence

Outcome Measures

Primary Outcomes (1)

• Proportion of participants (health care managers or policy makers) who appropriately consider and apply the evidence from each systematic review format

  The proportion of participants (health care managers or policy makers) who appropriately consider and apply the evidence from each systematic review format to the scenario as measured by agreement with an expert panel's recommendation. A panel of 4 health care managers or policy makers from our research team and 2 content experts. Their answers will provide the definition of appropriate application of the evidence. Two investigators who will be blind to allocation will independently determine if the participant's answer agrees with that from the expert panel. Disagreements will be resolved by a third investigator, independently. Agreement between investigators will be reported using the kappa statistic.

  This measure will be assessed at the particular time the intervention is administered (i.e., at the time the participant reads the systematic review format, an average of 2 hours).

Secondary Outcomes (4)

• Comprehension of the review

  This measures will be assessed at the particular time the intervention is administered (i.e., at the time the participant reads the systematic review format, an average of 2 hours).

• Intention to use evidence

  This measures will be assessed at the particular time the intervention is administered (i.e., at the time the participant reads the systematic review format, an average of 2 hours).

• Perceived tentativeness of research findings

  This measures will be assessed at the particular time the intervention is administered (i.e., at the time the participant reads the systematic review format, an average of 2 hours).

• Provisional opinion about the intervention

  This measures will be assessed at the particular time the intervention is administered (i.e., at the time the participant reads the systematic review format, an average of 2 hours).

Study Arms (2)

Novel systematic review format

EXPERIMENTAL

A 2-page summary of systematic review content that has been designed in collaboration with policy makers and health care managers. Participants receiving the intervention will be asked to read and answer questions using a novel systematic review format.

Other: Novel systematic review format

Traditional systematic review format

NO INTERVENTION

Control participants will be asked to read and answer questions using a traditional systematic review format.

Interventions

Novel systematic review format OTHER

A 2-page summary of systematic review content that has been designed in collaboration with policy makers and health care managers.

Novel systematic review format

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Health care managers from the Alberta SCNs, CAHO in Ontario, the RHAs and AQESSS in Quebec and RHAs from BC will be invited to participate.
• Policy makers/analysts from the Ontario, BC, Alberta and Quebec Ministries of Health

You may not qualify if:

• Health care managers or policy makers who are unwilling or unable to give informed consent.

Sponsors & Collaborators

• Unity Health Toronto: lead

Study Sites (1)

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

Study Officials

• Sharon e Straus

  Unity Health Toronto

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 5, 2017
• First Posted: February 2, 2017
• Study Start: May 16, 2017
• Primary Completion: November 30, 2019
• Study Completion: November 30, 2019
• Last Updated: May 7, 2020

Record last verified: 2020-05

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)